内地第五批国家药品带量采购目录被流出 据报有60个品种入围
据内地媒体报道,业内流出一份由国家组织药品联合采购办公室印发的《关於报送第五批国家组织药品集中采购品种范围相关采购数据的通知》。该通知公布带量采购药品名单显示,第五轮带量采购一共涉及60个品种,207个品规。相比此前第四批带量采购的45个品种,此轮带量采购所涉药品范围进一步扩大,品种和品规数均为历次之最。
该通知要求,於4月18日24:00前,各省可通过系统进行报量操作测试,4月19日正式启动报量,各省选择医疗机构直报或省级代报方式,填报相关药品预采购量,并於4月30日24:00前完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.